Aim: This study summarized the existing evidence on the outcomes and safety of anti-PD-1s, anti-PD-L1s and anti-CTLA-4s in pediatric patients with melanoma. Materials & methods: MEDLINE® and Embase w

NIAID Data Ecosystem20

Course of renal function from time of 1 st renal replacement therapy session until month 12 thereafter.

肾脏替代治疗

肾功能监测

Course of renal function from time of 1st renal replacement therapy session until month 12 thereafter.

NIAID Data Ecosystem20

基线与早期 g 氯皮质激素使用对晚期 NSCLC 患者免疫检查点抑制剂疗效

免疫抑制治疗评估

糖皮质激素影响

本研究旨在探讨糖皮质激素（GC）对免疫检查点抑制剂（ICI）疗效的具体影响，以及这种影响是否受 GC 给药时间和剂量的影响。监测 GC 给药期间中性粒细胞百分比和辅助/抑制 T 淋巴细胞比率 [NEUT % / （CD4+ / CD8+）] 的变化。

NIAID Data Ecosystem60

Supplementary Tables – Infection rates and tolerability of three different immunoglobulin administration modalities in patients with PID

免疫抑制治疗评估

原发性免疫缺陷病

Supplemental Table 1. Participant demographics and baseline characteristics. Supplemental Table 2. Annualized rates of infections by IgG route of administration for subgroup of participants sequential

Figshare2021-12-21 更新20

Biological changes associated with sirolimus introduction.

资源简介：

相关数据集